Germany’s COVID-19 Testing Leaps Again But Antibody Tests Not Ready
Executive Summary
Acting early but not too soon has made Germany a model of COVID-19 preparedness. Its testing rates are still increasing, and a new app is designed to ensure even greater detection efficiency is being developed. An antibody test eludes, however.
You may also be interested in...
EU’s COVID-19 IVD Guidelines Reflect Need For Nuanced Approach To Testing For Member States
New European Commission guidelines on COVID-19 IVD tests and their performance not only explain the regulatory requirements, but also detail why different levels of precision may be acceptable in different contexts.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.
UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024
Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.